Biopharma stocks climb on Merck and Eli Lilly earnings
Published . Updated .
Get this delivered to your inbox, and more info about our products and services.
Directly affected
Indirectly affected
- DIA SPDR Dow Jones Industrial Average ETF-1.7% 30d
SPDR Dow Jones Industrial Average ETF: it is a broad US stock-market fund. Linked by “stocks” (the broad US market) in this story.
- QQQ Invesco QQQ+2.3% 19d
Invesco QQQ: it is a broad US stock-market fund. Linked by “stocks” (the broad US market) in this story.
- XLV Health Care Select Sector SPDR
Health Care Select Sector SPDR holds the health sector that Eli Lilly and belongs to, so it often moves with news about it.
- JNJ Johnson & Johnson+0.4% 30d
Johnson & Johnson is a peer of Eli Lilly and in pharmaceutical preparations; rivals often move on the same news.
- ABBV AbbVie+8.5% 30d
AbbVie is a peer of Eli Lilly and in pharmaceutical preparations; rivals often move on the same news.
- ABT Abbott Laboratories-0.7% 30d
Abbott Laboratories is a peer of Eli Lilly and in pharmaceutical preparations; rivals often move on the same news.
- PFE Pfizer+6.7% 30d
Pfizer is a peer of Eli Lilly and in pharmaceutical preparations; rivals often move on the same news.
- VRTX Vertex Pharmaceuticals+2.6% 30d
Vertex Pharmaceuticals is a peer of Eli Lilly and in pharmaceutical preparations; rivals often move on the same news.
Price reaction, T-5 to T+3
| Ticker | T-5 | T-3 | T-1 | T0 | T+1 | T+2 | T+3 |
|---|---|---|---|---|---|---|---|
| MRK | -0.71% | -3.06% | base | after close | after close | after close | after close |
| LLY | -7.22% | -6.69% | base | after close | after close | after close | after close |
| DIANo price data for this ticker | — | — | — | — | — | — | — |
| QQQ | -1.57% | +0.81% | base | after close | after close | after close | after close |
| XLVNo price data for this ticker | — | — | — | — | — | — | — |
| JNJNo price data for this ticker | — | — | — | — | — | — | — |
| ABBVNo price data for this ticker | — | — | — | — | — | — | — |
| ABTNo price data for this ticker | — | — | — | — | — | — | — |
| PFENo price data for this ticker | — | — | — | — | — | — | — |
| VRTXNo price data for this ticker | — | — | — | — | — | — | — |
Closing-price change versus T-1, the last close before the story. T0 to T+3 fill in after each market close. Prices: Alpaca IEX.
Market Call
Think this story will push the stock up or down over the next three trading days? Make a free call and see what other readers think. Points are play money with no cash value.
Biopharma stocks climb on Merck and Eli Lilly earnings CNBC
Source: CNBC
Spdr Dow Jones Industrial Average Etf Trust (DIA) since this story, compared with the market
| Company | When | Move | Status |
|---|---|---|---|
| LLY | three days earlier | -6.69% | final price |
| LLY | five days earlier | -7.22% | final price |
| MRK | three days earlier | -3.06% | final price |
| MRK | five days earlier | -0.71% | final price |
| Invesco Qqq Trust, Series 1 (QQQ) | three days earlier | +0.81% | final price |
| Invesco Qqq Trust, Series 1 (QQQ) | five days earlier | -1.57% | final price |
Trades by members of Congress and officials in the stocks in this story
- Rep. Maria Elvira Salazar sold Merck (MRK), worth $1,001 - $15,000 on 24 Sep 2026. That is 35 days before publication. Filed 7 Oct 2026. View the filing.
- Rep. Maria Elvira Salazar bought Merck (MRK), worth $15,001 - $50,000 on 19 Aug 2026. That is 71 days before publication. Filed 9 Sep 2026. View the filing.
- Donald J Trump, an executive branch official, sold Merck (MRK), worth $250,001 - $500,000 on 31 Jul 2026. That is 90 days before publication. Filed 22 Sep 2026. View the filing.
- Rep. Rohit Khanna bought Eli Lilly (LLY) (held by a spouse), worth $1,001 - $15,000 on 4 Sep 2026. That is 55 days before publication. Filed 7 Oct 2026. View the filing.
- Rep. Rohit Khanna bought Johnson & Johnson (JNJ) (held by a spouse), worth $1,001 - $15,000 on 25 Sep 2026. That is 34 days before publication. Filed 7 Oct 2026. View the filing.
- Rep. Lloyd Doggett bought Johnson & Johnson (JNJ), worth $1,001 - $15,000 on 8 Sep 2026. That is 51 days before publication. Filed 5 Oct 2026. View the filing.
- Rep. Rohit Khanna bought Johnson & Johnson (JNJ) (held by a spouse), worth $1,001 - $15,000 on 4 Sep 2026. That is 55 days before publication. Filed 7 Oct 2026. View the filing.
- Rep. Pete Sessions sold AbbVie (ABBV), worth $15,001 - $50,000 on 14 Sep 2026. That is 45 days before publication. Filed 18 Sep 2026. View the filing.
- Rep. Rohit Khanna sold AbbVie (ABBV) (held by a spouse), worth $1,001 - $15,000 on 4 Sep 2026. That is 55 days before publication. Filed 7 Oct 2026. View the filing.
- Donald J Trump, an executive branch official, bought AbbVie (ABBV), worth $50,001 - $100,000 on 31 Jul 2026. That is 90 days before publication. Filed 22 Sep 2026. View the filing.
- Rep. Gilbert Cisneros bought Abbott Laboratories (ABT), worth $1,001 - $15,000 on 18 Sep 2026. That is 41 days before publication. Filed 12 Oct 2026. View the filing.
- Rep. Rohit Khanna bought Abbott Laboratories (ABT) (held by a spouse), worth $1,001 - $15,000 on 4 Sep 2026. That is 55 days before publication. Filed 7 Oct 2026. View the filing.
Public disclosure filings, not a recommendation. The filing link is the source document. News use of these reports still sits under 5 U.S.C. § 13107(c).
Who gains and who loses around Spdr Dow Jones Industrial Average Etf Trust (DIA)
Companies carried with this story
- DIA Spdr Dow Jones Industrial Average Etf Trust
In “Biopharma stocks climb on Merck and Eli Lilly earnings,” Spdr Dow Jones Industrial Average Etf Trust (DIA) is linked, with no stored direction, medium confidence. Reason on file: SPDR Dow Jones Industrial Average ETF: it is a broad US stock-market fund. Linked by “stocks” (the broad US market) in this story
- QQQ Invesco Qqq Trust, Series 1
In “Biopharma stocks climb on Merck and Eli Lilly earnings,” Invesco Qqq Trust, Series 1 (QQQ) is linked, with no stored direction, medium confidence. Reason on file: Invesco QQQ: it is a broad US stock-market fund. Linked by “stocks” (the broad US market) in this story
- IWM Ishares Tr
In “Biopharma stocks climb on Merck and Eli Lilly earnings,” Ishares Tr (IWM) is linked, with no stored direction, medium confidence. Reason on file: iShares Russell 2000 ETF: it is a broad US stock-market fund. Linked by “stocks” (the broad US market) in this story
- RSP Invesco Exchange Traded Fd T
In “Biopharma stocks climb on Merck and Eli Lilly earnings,” Invesco Exchange Traded Fd T (RSP) is linked, with no stored direction, medium confidence. Reason on file: Invesco S&P 500 Equal Weight ETF: it is a broad US stock-market fund. Linked by “stocks” (the broad US market) in this story
- VTI Vanguard Index Fds
Vanguard Index Fds (VTI) is linked, with no stored direction, medium confidence in the 29 Oct 2026 story “Biopharma stocks climb on Merck and Eli Lilly earnings.” Reason on file: Vanguard Total Stock Market ETF: it is a broad US stock-market fund. Linked by “stocks” (the broad US market) in this story
How “Biopharma stocks climb on Merck and Eli Lilly earnings” reaches Spdr Dow Jones Industrial Average Etf Trust (DIA)
The 29 Oct 2026 story “Biopharma stocks climb on Merck and Eli Lilly earnings” names Spdr Dow Jones Industrial Average Etf Trust (DIA) because of this story.
The link for Spdr Dow Jones Industrial Average Etf Trust (DIA) is this: SPDR Dow Jones Industrial Average ETF: it is a broad US stock-market fund. Linked by “stocks” (the broad US market) in this story
Invesco Qqq Trust, Series 1 (QQQ) is here too. Its reason reads: Invesco QQQ: it is a broad US stock-market fund. Linked by “stocks” (the broad US market) in this story
Dates and price levels for Spdr Dow Jones Industrial Average Etf Trust (DIA)
DIA traded between 504.92 and 522.62 across 20 sessions. The latest close on file is 515.65. IWM traded between 269.88 and 284.63 across 20 sessions. The latest close on file is 281.31. QQQ traded between 701.18 and 762.84 across 18 sessions. The latest close on file is 725.59.
A simple score for Spdr Dow Jones Industrial Average Etf Trust (DIA)
40 out of 100
“Biopharma stocks climb on Merck and Eli Lilly earnings” scores 40 out of 100. The score uses 1 sources, and 5 linked companies.